SCHEMBL527427

SCHEMBL527427

CCOC(=O)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL561038 0.97
Oxamate SCHEMBL29052445 0.90 ALOX15 (0.50)
SCHEMBL11047583 0.82 ALOX15 (0.43)
SCHEMBL14536877 0.82 ALOX15 (0.60)
SCHEMBL7262 0.81 ALDH1A1 (0.62)
SCHEMBL1331989 0.81 ALDH1A1 (0.62)
SCHEMBL9823358 0.81 ALDH1A1 (0.62)
SCHEMBL27693612 0.80
SCHEMBL21602155 0.79 ALOX15 (0.50)
SCHEMBL7209745 0.79 ALOX15 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 322 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119432405-A Dispersing agent, preparation method thereof, electrode material and secondary battery 深圳市德方创域新能源科技有限公司 2025-02-14 CN claimed
CN-118530132-A Preparation method of N-acyl amino acid surfactant 盐城工学院 2024-08-23 CN claimed
CN-118073699-A Method for recycling and preparing sodium-electricity positive electrode material from waste lithium batteries, sodium-electricity positive electrode material and application 广东邦普循环科技有限公司 2024-05-24 CN claimed
US-11894429-B2 Amorphous metal oxide semiconductor layer and semiconductor device NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2024-02-06 US claimed
US-11708344-B2 Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease HOFFMANN-LA ROCHE INC. (US) 2023-07-25 US claimed
US-20230074887-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE HOFFMANN-LA ROCHE INC. (US) 2023-03-09 US claimed
US-20220388972-A1 CHROMAN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION HOFFMANN-LA ROCHE INC. (US) 2022-12-08 US claimed
CN-114292409-B Metal organic framework material with ethane and methane adsorption separation function and preparation method thereof 西北大学 2022-12-06 CN claimed
US-20220328635-A1 AMORPHOUS METAL OXIDE SEMICONDUCTOR LAYER AND SEMICONDUCTOR DEVICE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2022-10-13 US claimed
EP-3894004-A1 CHROMAN-4-ONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION F. Hoffmann-La Roche AG (CH) 2021-10-20 EP claimed
WO-2020070088-A1 FLAVONE DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS DISEASE F. HOFFMANN-LA ROCHE AG (CH) 2020-04-09 WO claimed
CN-110938233-A Hindered amine light stabilizer for nylon and preparation method thereof 宿迁联盛科技股份有限公司 2020-03-31 CN claimed
CN-101611015-A Indazolyl ester and indazolyl amide derivatives for the treatment of glucocorticoid receptor mediated disorders ASTRAZENECA AB (SE) 2009-12-23 CN claimed
EP-2041085-A1 PYRROLE DERIVATIVES AND THEIR METHODS OF USE Abbott Laboratories (US) 2009-04-01 EP claimed
WO-2008002974-A1 PYRROLE DERIVATIVES AND THEIR METHODS OF USE ABBOTT LABORATORIES (US) 2008-01-03 WO claimed
WO-2006016237-A2 HETEROCYCLIC DERIVATIVES AS ANTI-INFLAMMATORY AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-02-16 WO claimed
US-5393760-A Cardiovascular disorders, antitumor agents HOFFMANN-LA ROCHE INC. (US) 1995-02-28 US claimed
EP-0468231-B1 Guanidins HOFFMANN LA ROCHE (CH) 1994-09-21 EP claimed
EP-0468231-A2 Guanidins F. HOFFMANN-LA ROCHE AG (CH) 1992-01-29 EP claimed
US-3936463-A ANALGESIC BAYER AKTIENGESELLSCHAFT (DT) 1976-02-03 US claimed